• Revenue increased 30.7% to $48.2m, driven by acquisitions and organic growth
• EBITDA increased 60.1% to $8.3m, reflecting operating leverage and improved margins
• Profit before tax increased 62.1% to $6.3m, highlighting the scalability of the business

Austco Healthcare Ltd reported a strong 1H-26 performance, with revenue increasing 30.7% to $48.2m and EBITDA rising 60.1% to $8.3m. The results highlight the company's operating leverage, consistent execution, and the successful integration of recent acquisitions. Gross profit increased 33.6% to $25.2m, with gross margins improving to 52.2%, reflecting scale benefits and operational efficiency. Overhead expenses grew at a lower rate than revenue, demonstrating the scalability of Austco's business model. Profit before tax increased 62.1% to $6.3m, and profit after tax rose 61.7% to $4.7m. The company's geographic revenue mix remained diversified, with Australia and New Zealand contributing 56% of group revenue, North America 32%, Asia 8%, and Europe 4%. EBITDA margins improved from 14.0% in 1H-25 to 17.1% in 1H-26, driven by scale benefits and operational leverage across key regions. Austco ended the period with $15.2m in cash and no debt, providing flexibility to fund reinvestment, innovation, and selective M&A. The company continues to evaluate strategic acquisition opportunities aligned with its capability and geographic priorities, maintaining a disciplined approach to capital allocation.

Austco expects to maintain its focus on execution, balance sheet strength, and long-term value creation within a dynamic healthcare funding environment.